The FDA has granted Breakthrough Therapy Designation for oral infigratinib (BridgeBio Pharma), which is currently under development for children with achondroplasia, according to a press release from ...
In a recently-published study, results demonstrated that residence in low-income, low-food access neighborhoods in early life was linked to higher subsequent child body mass index (BMI) and higher ...
California's AB 899 mandates baby food manufacturers test for toxic metals like arsenic, cadmium, lead, and mercury, increasing transparency and safety. The law, effective January 2025, may influence ...